BMR Biomed Realty Trust

After the close on Tuesday, real estate investment trust Biomed Realty Trust Inc (BMR) reported that its second quarter funds from operations almost doubled year-over-year. Both the company's core funds from operations and revenues were able to top Wall Street views. The San Diego, California-based company posted a second quarter funds from operations (FFO) of $80.51 million, or 40 cents per share, up from $40.68 million, or 24 cents per share, in the same period in 2012. Funds from operations is a typical measurement of earnings when looking at real estate investment trusts. It usually adds depreciation and amortization expenses to earnings, minus gains from the sale of properties. Biomend's core funds from operations (CFFO) came in at $82.63 million, or 41 cents per share, in the second quarter. According to analysts polled by Thomson Reuters, the company was expected to see 39 cents per share in CFFO. The company's overall net earnings came in at $14.80 million, or 8 cents per share, versus last year's loss of $8.71 million, or 6 cents per share. Revenues for the quarter came in at $159.6 million, about 28% higher than last year's second quarter revenues of $124.8 million. Analysts were expecting the company to see $143.47 million in revenues. Looking forward, the company said it expects full year FFO to be between $1.43 and $1.47 per share. Analysts expect Biomed to see $1.48 per share in FFO. Biomed Realty Trust shares were down 8 cents, or 0.37%, during early morning trading on Wednesday. The stock is up 3.98% year-to-date. The Bottom Line Shares of Biomed Realty (BMR) offer a dividend yield of 4.64% based on last night's closing price of $20.25 and the company's annualized dividend payout of 94 cents per share. Biomed Realty Trust Inc (BMR) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.3 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.